Indian BMI standard
When is medication considered?
Indian guidance uses lower BMI cut-offs than Western guidelines. Anti-obesity medication, including GLP-1 receptor agonists, is considered after a structured lifestyle intervention — typically at a BMI of 27–27.5 or above, or from a BMI of 25 when a related condition such as type 2 diabetes, prediabetes, hypertension, dyslipidaemia, NAFLD, OSA or cardiovascular disease is present.
ESI Clinical Practice Guidelines for Obesity in India, 2025 ↗
